December 18, 2017

Atrial Fibrillation Antiarrhythmic Drugs– interviews Prof. John Camm

In this video from Boston Atrial Fibrillation Symposium 2010, Professor John Camm discusses the two newest antiarrhythmic drugs, dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. John Camm is Professor of Clinical Cardiology at St. George’s University of London in the UK. A full video transcript can be found at: